Coherus Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.59

-0.04 (-2.45%)

As of May 16, 2:03 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +2,176.7% upside

Low Target $24.75

Average Target $36.20

High Target $54.95

Current Price $1.59

Current
$1.59

Target
$36.20

$24.75 $36.20 avg $54.95

Scenario Analysis

Bear Case

$24.75

1,456.6%

Low target

Base Case

$36.20

+2,176.7%

Avg target

Bull Case

$54.95

+3,356.0%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.62

-39.2% from high

52-Week Low

$0.71

+123.9% from low

Target vs 52W High

$36.20

+1,283.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%